A Structured Review and Critical Analysis of RCTs on Nandrolone Decanoate’s Cardiac Effects in Young Exercising Man
Lucas Caseri Câmara, Diogo Pinto Viana
Journal of Pharmaceutical Research International · pp. 59–67 · Published 7 Mar 2025
10.9734/jpri/2025/v37i37669Abstract
Aims: The cardiovascular risks associated with anabolic-androgenic steroid (AAS) use, particularly nandrolne decanoate (ND), remain a topic of debate due to conflicting evidence from different types of studies. While observational research frequently reports adverse cardiac effects, findings from randomized controlled trials (RCTs) suggest otherwise. This review aims to critically assess the available RCTs evaluating the impact of ND on cardiac morphology and function, with a focus on their methodological quality and clinical relevance. Study Design: Structured review of randomized controlled trials. Methods: A systematic literature search was conducted to identify RCTs that examined the effects of ND on cardiac function. The analysis included study design, sample size, inclusion/exclusion criteria, cardiac evaluation methods, and reported outcomes. The methodological quality of each study was assessed using the Jadad scale to ensure a rigorous evaluation of the evidence. Results: The two reviewed RCTs, which were of moderate to high methodological quality, did not report clinically significant cardiac dysfunction in healthy individuals after short-term exposure to ND. However, these findings contrast with several observational studies, where users—often exposed to uncontrolled conditions and higher doses—frequently present with structural and functional cardiac changes. A key limitation of the RCTs was their small sample sizes, short follow-up durations, and reliance on conventional imaging techniques, which may not be sensitive enough to detect subtle cardiac alterations. Conclusion: While current RCTs do not provide strong evidence of cardiovascular harm from ND, their methodological limitations underscore the need for further research. Future trials with larger sample sizes, higher statistical power, and more advanced cardiac imaging techniques will be crucial in clarifying the true impact of ND on the heart. Until more definitive data are available, routine cardiac monitoring should be considered for individuals using ND, particularly those on prolonged or high-dose regimens.
Cited by 0
No indexed citations yet.
Related research
- ‘Efficacy of GLP-1 Receptor Agonists’ in Hypertriglyceridemia: A Systemic Review and Meta Analysis — shares topic coverage
- Modulation of Immunological and Hematological Disturbances of Diabetes Mellitus by Diets Containing Combined Leaves of Vernonia amygdalina and Gongronema latifolium — shares topic coverage
- Paradoxical Lipid Patterns and Elevated Atherogenic Risk in HIV Patients on Antiretroviral Therapy from the Rivers State University Teaching Hospital, Nigeria — shares topic coverage
- Carotid Intima-media Thickness and Risk of Cardiovascular Disease among Healthy Adult Volunteers in North Eastern Nigeria — shares topic coverage
- Comparison of Cardiovascular Risk in Microalbuminuric and Normoalbuminuric Type 2 Diabetic Patients in Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
20
Page views
0
PDF downloads
2
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.